These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 24481429)

  • 1. [Life style and metabolic control in DiabetIMSS program].
    Figueroa-Suárez ME; Cruz-Toledo JE; Ortiz-Aguirre AR; Lagunes-Espinosa AL; Jiménez-Luna J; Rodríguez-Moctezuma JR
    Gac Med Mex; 2014; 150(1):29-34. PubMed ID: 24481429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lifestyle and metabolic control in patients with type 2 diabetes mellitus. Construct validation of IMEVID questionnaire].
    López-Carmona JM; Rodríguez-Moctezuma JR; Ariza-Andraca CR; Martínez-Bermúdez M
    Aten Primaria; 2004 Jan; 33(1):20-7. PubMed ID: 14746741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development and initial validation of an instrument to measure the lifestyles of type 2 diabetes mellitus patients 2].
    López-Carmona JM; Ariza-Andraca CR; Rodríguez-Moctezuma JR; Munguía-Miranda C
    Salud Publica Mex; 2003; 45(4):259-68. PubMed ID: 12974043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Depressive disorder and issues related to DiabetIMSS beneficiaries].
    Fu-Espinosa M; Trujillo-Olivera LE
    Rev Med Inst Mex Seguro Soc; 2013; 51(1):80-5. PubMed ID: 23550412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dietary intake and life style on bone density in patients with diabetes mellitus type 2.
    de Luis Román DA; Aller R; Perez Castrillon JL; De Luis J; Gonzalez Sagrado M; Izaola O; Romero E; Martín Escudero JC; Herreros V
    Ann Nutr Metab; 2004; 48(3):141-5. PubMed ID: 15133318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of the diabetes education program (DiabetIMSS) on clinical and biochemical parameters].
    León-Mazón MA; Araujo-Mendoza GJ; Linos-Vázquez ZZ
    Rev Med Inst Mex Seguro Soc; 2013; 51(1):74-9. PubMed ID: 23550411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The First Step First Bite Program: guidance to increase physical activity and daily intake of low-glycemic index foods.
    Cheong SH; McCargar LJ; Paty BW; Tudor-Locke C; Bell RC
    J Am Diet Assoc; 2009 Aug; 109(8):1411-6. PubMed ID: 19631048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic control after discharge from the DiabetIMSS program].
    Carrillo-Medrano JG; Villegas-Saldívar KL; Martínez-Caldera E
    Rev Med Inst Mex Seguro Soc; 2021 Aug; 59(4):264-273. PubMed ID: 35006658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
    Schiel R; Müller UA; Rauchfub J; Sprott H; Müller R
    Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics, obesity, and environmental risk factors associated with type 2 diabetes.
    Bener A; Zirie M; Al-Rikabi A
    Croat Med J; 2005 Apr; 46(2):302-7. PubMed ID: 15849854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [To face up the disease strategy as a risk factor for the life style in type 2 diabetics].
    Gómez-Rocha SA; Galicia-Rodríguez L; Vargas-Daza ER; Martínez-González L; Villarreal-Ríos E
    Rev Med Inst Mex Seguro Soc; 2010; 48(5):539-42. PubMed ID: 21205504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of machine learning methodology to assess the performance of DIABETIMSS program for patients with type 2 diabetes in family medicine clinics in Mexico.
    You Y; Doubova SV; Pinto-Masis D; Pérez-Cuevas R; Borja-Aburto VH; Hubbard A
    BMC Med Inform Decis Mak; 2019 Nov; 19(1):221. PubMed ID: 31718638
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.